In vivo isogenic modelling unveils TP53 -associated relapse trajectories in T-cell acute lymphoblastic leukemia
Preprint
Abstract
Many patients with T-cell acute lymphoblastic leukemia (T-ALL) relapse into a treatment-resistant disease. The mechanisms driving relapse remain largely elusive, in part due to the lack of faithful experimental models. Here, we leveraged patient-derived xenograft (PDX) pairs generated from diagnosis and relapse T-ALLs to functionally address the cellular mechanisms driving TP53- altered relapse. Beyond inter-T-ALL variability, comparative analyses revealed a unique, cell-intrinsic relapse phenotype that includes greater leukemia-initiating capacity and that can be conferred to diagnosis cells by TP53 silencing. Transcriptomic profiling linked the relapse phenotype to deregulated OXPHOS metabolism and MYC signaling. Integration of single-cell profilings uncovered TP53- wildtype cell populations at diagnosis expressing a relapse profile, possibly reflecting a pre-existing modulation of TP53 signaling. These cells sequentially evolved towards biallelic TP53 inactivation at relapse. Collectively, our findings support a model in which T-ALL relapses emerge from a selected pre-existing transcriptional state characterized by deregulated metabolism that favors subsequent TP53 inactivation.Keywords
This publication has 56 references indexed in Scilit:
- Understanding the complexity of p53 in a new era of tumor suppressionCancer Cell, 2024
- Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemiaCell Stem Cell, 2023
- Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic LeukemiaThe Journal of Pediatrics, 2018
- PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyCell Stem Cell, 2018
- Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic LeukemiaCancer Cell, 2018
- Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL studyBlood Cancer Journal, 2016
- Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic LeukemiaCancer Cell, 2016
- Bone Marrow Failure in Fanconi Anemia Is Triggered by an Exacerbated p53/p21 DNA Damage Response that Impairs Hematopoietic Stem and Progenitor CellsCell Stem Cell, 2012
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assaysJournal of Immunological Methods, 2009
- Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemiaCancer Cell, 2002